Evidence map›Paper›PMID 27357166›Full record

ArticleThe Journal of physiology2016

Xanthine oxidoreductase mediates membrane docking of milk-fat droplets but is not essential for apocrine lipid secretion.

Jenifer Monks, Monika Dzieciatkowska, Elise S Bales, David J Orlicky, Richard M Wright, James L McManaman

Abstract read
In one paragraph

Article in The Journal of physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Targeting LiverPharmaceutics · 2024
    Article
  4. Article
  5. Review
  6. Review: genetic background of milk fatty acid synthesis in bovines.Tropical animal health and production · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Knockout of butyrophilin subfamily 1 member A1 (Journal of animal science and biotechnology · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Jenifer MonksDivision of Reproductive Sciences, Department of Obstetrics and Gynecology, School of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO, 80045, USA. jenifer.monks@ucdenver.edu.ORCID 0000-0002-7990-3389
Monika DzieciatkowskaBiochemistry Department, School of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO, 80045, USA.
Elise S BalesDivision of Reproductive Sciences, Department of Obstetrics and Gynecology, School of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO, 80045, USA.
David J OrlickyDepartment of Pathology, School of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO, 80045, USA.
Richard M Wright
James L McManamanDivision of Reproductive Sciences, Department of Obstetrics and Gynecology, School of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO, 80045, USA.

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Wendy M Kohrt · 1995 to 2026
$32.6M
The functional role of microRNAs in the normal mammary glandP01HD038129 · NICHD · UNIVERSITY OF COLORADO DENVER · PI ANDERSON, STEVEN M · 2000 to 2015
$15.2M
MECHANISMS OF MILK LIPID SECRETIONR01HD045965 · NICHD · UNIVERSITY OF COLORADO DENVER · PI MCMANAMAN, JAMES LEWIS · 2004 to 2013
$2.8M
Postnatal Actions of Maternal Obesity on Neonatal Metabolic HealthR01HD075285 · NICHD · UNIVERSITY OF COLORADO DENVER · PI MACLEAN, PAUL S., MCMANAMAN, JAMES LEWIS · 2013 to 2017
$1.6M
Functional aspects of SREBP1c in intact skeletal muscleK01DK067403 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MACLEAN, PAUL S · 2005 to 2007
$397k
NCATS NIH HHS UL1 TR001082NCI NIH HHS P30 CA046934NICHD NIH HHS P01 HD038129NICHD NIH HHS R01 HD045965NICHD NIH HHS R01 HD075285NIDDK NIH HHS K01 DK067403NIDDK NIH HHS P30 DK048520
6 · The paper itself

Abstract

key pointsXanthine oxidoreductase (XOR) modulates milk lipid secretion and lactation initiation. XOR is required for butyrophilin1a1 clustering in the membrane during milk lipid secretion. XOR mediates apical membrane reorganization during milk lipid secretion. Loss of XOR delays milk fat globule secretion. XOR loss alters the proteome of milk fat globules. ABSTRACT: Apocrine secretion is utilized by epithelial cells of exocrine glands. These cells bud off membrane-bound particles into the lumen of the gland, losing a portion of the cytoplasm in the secretion product. The lactating mammary gland secretes milk lipid by this mechanism, and xanthine oxidoreductase (XOR) has long been thought to be functionally important. We generated mammary-specific XOR knockout (MGKO) mice, expecting lactation to fail. Histology of the knockout glands showed very large lipid droplets enclosed in the mammary alveolar cells, but milk analysis showed that these large globules were secreted. Butyrophilin, a membrane protein known to bind to XOR, was clustered at the point of contact of the cytoplasmic lipid droplet with the apical plasma membrane, in the wild-type gland but not in the knockout, suggesting that XOR mediates 'docking' to this membrane. Secreted milk fat globules were isolated from mouse milk of wild-type and XOR MGKO dams, and subjected to LC-MS/MS for analysis of protein component. Proteomic results showed that loss of XOR leads to an increase in cytoplasmic, cytoskeletal, Golgi apparatus and lipid metabolism proteins associated with the secreted milk fat globule. Association of XOR with the lipid droplet results in membrane docking and more efficient retention of cytoplasmic components by the secretory cell. Loss of XOR then results in a reversion to a more rudimentary, less efficient, apocrine secretion mechanism, but does not prevent milk fat globule secretion.

Indexed as

AnimalsApocrine GlandsButyrophilinsCell MembraneCytoplasmEpithelial CellsFemaleGlycolipidsGlycoproteinsHumansLactationLipid DropletsLipid MetabolismLipidsMammary Glands, HumanMembrane ProteinsButyrophilinsGlycolipidsGlycoproteinsLipidsMembrane Proteinsmilk fat globuleXanthine Dehydrogenaseapocrine secretionlactationLC_MS/MSmilk fat globuleproteomicsXanthine Oxidoreductase

Identifiers

PMID27357166
PMCPMC5063925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.